ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

OCUL Ocular Therapeutix Inc

6,27
-0,02 (-0,32%)
16 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Ocular Therapeutix Inc OCUL NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,02 -0,32% 6,27 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,30 5,93 6,45 6,27 6,29
mais cotações »

Notícias Recentes

Data Hora Fonte Título
07/05/202417:05GLOBEOcular Therapeutix™ Reports First Quarter 2024 Results
06/05/202421:16GLOBEOcular Therapeutix Reports Inducement Grants Under Nasdaq..
06/05/202408:30GLOBEOcular Therapeutix™ to Present at Two Upcoming Investor..
03/05/202408:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01/05/202408:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
11/03/202407:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
19/02/202411:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15/02/202410:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
13/02/202409:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
18/12/202318:01GLOBEOcular Therapeutix™ Announces Closing of Public Offering of..
14/12/202300:09GLOBEOcular Therapeutix™ Announces Pricing of Public Offering of..
13/12/202321:07DJNStocks to Watch: Adobe, Amtech Systems, Ocular Therapeutix
13/12/202318:01GLOBEOcular Therapeutix™ Announces Proposed Public Offering of..
08/11/202310:00GLOBEOcular Therapeutix™ to Present at Three Upcoming Investor..
07/11/202318:01GLOBEOcular Therapeutix™ Provides Third Quarter 2023 Financial..
01/11/202309:00GLOBEOcular Therapeutix™ Receives FDA Agreement Under Special..
31/10/202310:00PRNUSAffaMed Therapeutics Announced Positive Top-Line Results..
24/10/202309:00GLOBEOcular Therapeutix™ To Report Third Quarter 2023 Financial..
03/10/202317:01GLOBEOcular Therapeutix™ Announces Initiation of its First..
06/09/202309:00GLOBEOcular Therapeutix™ to Present at Three Upcoming Investor..
09/08/202309:00GLOBEOcular Therapeutix™ to Present at the H.C. Wainwright 3rd..
07/08/202317:01GLOBEOcular Therapeutix™ Provides Second Quarter 2023 Financial..
24/07/202309:00GLOBEOcular Therapeutix™ To Report Second Quarter 2023 Financial..
12/07/202309:00GLOBEOcular Therapeutix™ Announces Appointment of New Board..
10/06/202319:30GLOBEOcular Therapeutix™ Announces 12-Month Topline Data from..
07/06/202309:00GLOBEOcular Therapeutix™ Completes Enrollment of the HELIOS..
05/06/202317:01GLOBEOcular Therapeutix™ To Present 12-Month Top-Line Data from..
01/06/202309:00GLOBEOcular Therapeutix™ to Present at the Jefferies Global..